Citations

Mayo Clinic

Showing 10 of 108602 citations.

Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works
Segraves, J. , Cartin‐Ceba, Rodrigo , Leise, Michael D. , Krowka, Michael J. , Segraves, Justin M

Hepatology Research | July 1, 2017 | Volume: 48 | Issue: 3 | Pages: No page available

10.1111/hepr.12930 | PMID 28667665 Get It

AimPortopulmonary hypertension is a serious complication of portal hypertension that can lead to right heart failure and death. To our knowledge, an association between portopulmonary hypertension and prior splenectomy has not been described previously. The goals of this study were to describe the frequency of splenectomy in portopulmonary hypertension and compare selected parameters between portopulmonary hypertension subgroups.MethodsThis is a retrospective analysis of patients diagnosed with portopulmonary hypertension between 1 January 1988 and 30 June 2015 at Mayo Clinic (Rochester, MN, USA). We compared age, sex, right ventricle systolic pressure by echocardiography, and right heart catheterization measurements/calculations among subgroups of portopulmonary hypertension patients with splenectomy and/or autoimmune liver disease (autoimmune hepatitis/primary biliary cirrhosis/primary sclerosing cholangitis).ResultsThe cohort consisted of 141 patients, of whom 8 (6%) had a history of splenectomy prior to the development of portopulmonary hypertension. Twenty‐seven (19%) portopulmonary hypertension patients had autoimmune liver disease, and 5 of 8 (62.5%) splenectomized portopulmonary hypertension patients had autoimmune liver disease. No significant difference was noted in right heart catheterization measurements/calculations between splenectomized and non‐splenectomized portopulmonary hypertension patients. Right ventricle systolic pressure by echocardiography was significantly higher in those splenectomized.ConclusionsPrior history of splenectomy in portopulmonary hypertension was 6% in this cohort. The combination of autoimmune liver disease and splenectomy in portopulmonary hypertension was not uncommon. History of splenectomy in patients with portal hypertension and/or autoimmune liver disease may have clinical implications.
EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
Mehner, Christine , Oberg, Ann L. , Goergen, Krista M., Kalli, Kimberly R., Goode, Ellen L. , Keeney, Gary L., Jatoi, Aminah , Radisky, Evette S. , Radisky, Derek C. , Maurer, Matthew J. , Nassar, Aziza , Radisky, Evette S

Genes & Cancer | July 1, 2017 | Volume: 8 | Issue: 5-6 | Pages: 589-599

10.18632/genesandcancer.142 | PMID 28740577 Get It

KEYNOTE: WHAT COULD COME FROM UNDERSTANDING THE BIOLOGY OF AGING?
Kirkland, James L. , Rooij, Sophia E. de , Kuipers, Folkert

Innovation in Aging | July 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 1081-1082

10.1093/geroni/igx004.3966 Get It

PROOF-OF-CONCEPT CLINICAL TRIALS OF INTERVENTIONS THAT TARGET FUNDAMENTAL AGING PROCESSES
Kirkland, James L.

Innovation in Aging | July 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 1082-1082

10.1093/geroni/igx004.3967 Get It

Burnout, career satisfaction, and well-being among US neurology residents and fellows in 2016
Levin, Kerry H., Keran, Christopher M. , Busis, Neil A. , Foster, Laura A. , Molano, Jennifer Rose V. , O’Donovan, Cormac A. , Ratliff, Jeffrey , Schwarz, Heidi B., Sloan, Jeff A. , Cascino, Terrence L., O'Donovan, Cormac A, Ratliff, Jeffrey B, Shanafelt, Tait D. , Keran, Christopher M

Neurology | July 1, 2017 | Volume: 89 | Issue: 5 | Pages: 492-501

10.1212/wnl.0000000000004135 | PMID 28667180 Get It

The Utility of Sentinel Node Biopsy for Sinonasal Melanoma
Oldenburg, Michael , Oldenburg, Michael S, Price, Daniel L.

Journal of Neurological Surgery Part B: Skull Base | June 30, 2017 | Volume: 78 | Issue: 05 | Pages: 425-429

10.1055/s-0037-1603960 | PMID 28875122 Get It

Objective Report two positive sentinel node biopsies for sinonasal melanoma. Design Retrospective review. Setting Academic tertiary care center. Participants Patients who underwent sentinel node biopsy for sinonasal melanoma between November 1, 2014 and November 1, 2015. Main Outcome Measures Clinical course. Results Two patients were identified. Patient 1 (83M) presented with a sinonasal melanoma anterior to the left inferior turbinate and was clinically N0 neck. Lymphoscintigraphy revealed two sentinel nodes in the ipsilateral and three in the contralateral cervical basins. The left level I sentinel node was positive for melanoma and lymphadenectomy showed no additional metastases.Patient 2 (71F) presented after incomplete resection of a sinonasal melanoma of the left posterior maxillary sinus wall and was clinically N0 neck. Lymphoscintigraphy with single-photon emission computed tomography (SPECT/CT) localization revealed one sentinel node in the parapharyngeal space and another in the ipsilateral cervical basin. Metastatic melanoma was found in both nodes and completion lymphadenectomy was negative for additional disease.Both patients developed distant metastasis in less than 1 year after surgical resection but responded well to adjuvant immunomodulatory chemotherapeutic agents. Conclusion Sentinel node biopsy for sinonasal melanoma can provide crucial clinical evidence of regional metastasis prior to overt clinical signs and symptoms. This intraoperative tool has the potential to improve detection of regional metastasis and improve long-term outcomes of this aggressive malignancy.
PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry
Jabbour, Tony El , Sheehan, Christine E., Geiersbach, Katherine B. , Boguniewicz, Ann, Ainechi, Sanaz, Bronner, Mary P. , Jones, David , Lee, Hwajeong , Ross, Jeffrey S , Affolter, Kajsa E. , Lee, Hwajeong , Geiersbach, Katherine

Journal of Clinical Pathology | June 30, 2017 | Volume: 71 | Issue: 1 | Pages: 46-51

10.1136/jclinpath-2017-204525 | PMID 28667193 Get It

Aims Routine application of PD-L1 immunohistochemistry (IHC) in colorectal cancer (CRC) is limited due to lack of standardized scoring criteria, antibody clones, and intratumoral staining heterogeneity. We assessed PD-L1 protein expression on full face CRC tissue sections and applied two algorithms based on the published clinical trials that support the recent FDA approval for immune checkpoint inhibitors (ICPI) therapy in non-small cell lung cancer (NSCLC). Methods PD-L1/CD274 IHC (Roche/Ventana, clone SP142) was performed on representative tumour blocks from 52 mismatch repair-deficient (MMR-D) and 52 MMR-proficient (MMR-P) CRCs. Membranous PD-L1 expression was scored for the tumour cell (TC) and tumour-infiltrating immune cell (IC) components. PD-L1 positivity status was determined based on the published NSCLC clinical trials that utilized the Ventana SP142 assay. Hybrid capture-based comprehensive genomic profiling (CGP) was performed on a separate set of 2268 clinically advanced CRCs and the frequency of PD-L1/PD-L2 amplification was determined. Results PD-L1 expression in the TC and IC correlated with MMR-D (p=0.013, p<0.0001), T stage (p=0.036, p=0.0036) and clinical stage (p=0.022, p=0.0037). PD-L1 positivity status correlated with MMR-D by two algorithms. Five of 2268 (<1%) advansced CRCs demonstrated amplification of either the PD-L1 or PD-L2 genes by CGP. Conclusions PD-L1 expression in TC and IC is associated with advanced stage and MMR-D. PD-L1 positivity status by the published algorithm is associated with MMR-D. PD-L1 amplification is extremely uncommon in CRC. Evaluation of whole tissue section and incorporation of IC staining enhance the sensitivity to screen patients who may benefit from ICPI therapy.
THE LINK BETWEEN DEPRESSION AND FRAILTY AMONG OLDER VETERANS FROM A VA GERIATRIC CLINIC
Kim, Hui Ji , Canaday, David H. , Burant, Christopher J. , Higgins, Paul , Hornick, Thomas R.

Innovation in Aging | June 30, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 818-818

10.1093/geroni/igx004.2952 Get It

Advances in peripheral nerve regeneration as it relates to VCA
Suchyta, Marissa , Sabbagh, M. Diya , Morsy, Mohamed , Moran, Steven L. , Mardini, Samir

Vascularized Composite Allotransplantation | June 30, 2017 | Volume: 3 | Issue: 1-2 | Pages: 75-88

10.1080/23723505.2017.1344347 Get It

Quality measurement for rhinosinusitis: a review from the Quality Improvement Committee of the American Rhinologic Society
Rudmik, Luke , Mattos, José L. , Schneider, John S. , Manes, Peter R., Stokken, Janalee K., Lee, Jivianne, Schlosser, Rodney J. , Reh, Douglas D., Setzen, Michael, Stokken, Janalee K. , Lee, Jivianne T. , Higgins, Thomas S , Soler, Zachary M. , Schlosser, Rodney J , Carlson, Matthew L , Mattos, Jose

International Forum of Allergy & Rhinology | June 30, 2017 | Volume: 7 | Issue: 9 | Pages: 853-860

10.1002/alr.21983 | PMID 28665549 Get It

BackgroundMeasuring quality outcomes is an important prerequisite to improve quality of care. Rhinosinusitis represents a high value target to improve quality of care because it has a high prevalence of disease, large economic burden, and large practice variation. In this study we review the current state of quality measurement for management of both acute (ARS) and chronic rhinosinusitis (CRS).MethodsThe major national quality metric repositories and clearinghouses were queried. Additional searches included the American Academy of Otolaryngology–Head and Neck Surgery database, PubMed, and Google to attempt to capture any additional quality metrics.ResultsSeven quality metrics for ARS and 4 quality metrics for CRS were identified. ARS metrics focused on appropriateness of diagnosis (n = 1), antibiotic prescribing (n = 4), and radiologic imaging (n = 2). CRS quality metrics focused on appropriateness of diagnosis (n = 1), radiologic imaging (n = 1), and measurement of patient quality of life (n = 2). The Physician Quality Reporting System (PQRS) currently tracks 3 ARS quality metrics and 1 CRS quality metric. There are no outcome‐based rhinosinusitis quality metrics and no metrics that assess domains of safety, patient‐centeredness, and timeliness of care.ConclusionsThe current status of quality measurement for rhinosinusitis has focused primarily on the quality domain of efficiency and process measures for ARS. More work is needed to develop, validate, and track outcome‐based quality metrics along with CRS‐specific metrics. Although there has been excellent work done to improve quality measurement for rhinosinusitis, there remain major gaps and challenges that need to be considered during the development of future metrics.